Towards standardization of an in vitro method of drug absorption

Pharmacopeial Forum

Volumn 27, Issue 4, 2001, Pages 2916-2921

  Volpe, Donna A ^a,b   Faustino, Patrick J ^a,b   Lawrence, X ^a,b   Hussain, Ajaz S ^a,b  

^a Division of Product Quality Research

^b Division of Cellular and Gene Therapies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 12244290744     PISSN: 03634655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Borchardt, R.T. Rational delivery strategies for the design of peptides with enhanced oral delivery. Drug Dev. Ind. Pharm. 1994,20(4), 463-483.
2. Wilson, G. Cell culture techniques for the study of drug transport. Eur. J. Drug Metab. Pharmacokinet. 1990, 15 (2), 159-163.
3. Hillgren, K.M.; Kato, A.; Borchardt, R.T. In vitro systems for studying intestinal drug absorption. Med. Res. Rev. 1995, 15(2), 83109.
4. Quaroni, A.; Hochman, J. Development of intestinal cell culture models for drug transport and metabolism studies. Adv. Drug Delivery Rev. 1996, 22 (1-2), 3-52.
5. Hidalgo, I.J.; Raub, T.J.; Borchardt, R.T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989, 96 (3), 736749.
6. Délie, F.; Rubas, W. A human colonie cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit. Rev. Ther. Drug Carrier Syst. 1997, 14 (3), 221-286.
7. Gan, L.S; Thakker, D.R. Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers poised by the intestinal epithelium. Adv. Drug Delivery Rev. 1997, 23 (1-2), 77-98.
8. Pinto, M.; Robine-Leon, S.; Appay, M.D.; Kedinger, M.; Traidou, N.; Dussauix, E.; Lacroix, B.; Simon-Assmann, P.; Huffen, K.; Fogh, K.; Zweibaum, A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Blol. Chem. 1983, 47, 323-330.
9. Hidalgo, I.J.; Li, J. Carrier-mediated transport and efflux mechanisms in Caco-2 cells. Adv. Drug Delivery Rev. 1996,22 (1-2), 5366.
10. Artursson, P. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells..xJ. Pharm. Sci. 1990, 79 (6), 476-482.
11. Meunier, V.; Bourrié, M.; Berger, Y.; Fabre, G. The human intestinal epithelial cell line Caco-2: pharmacological and pharmacokinetic applications. Cell. Blol. Toxicol. 1995, 11 (3-4), 187-194.
12. Artursson, P.; Karisson, J.; Ocklind, G.; Schipper, N. Studying transport processes in absorptive epithelia. In Cell Models of Epithelial Tissues-A Practical Approach; Shaw A., Ed.; IRL: Oxford, 1996; pp 111-133.
13. Prueksaritanont, T.; Gorham, L.M.; Hochman, J.H.; Tran, L.O.; Vyas, K.P. Comparative studies of drug metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metab. Dispos. 1996, 24 (6), 634-642.
14. Herold, G.; Regler, G.; Rogler, D.; Stange, E.F. Morphology of Caco-2 cells varies in different cell batches. In Vitro Cellular and Developmental Biology-Animal 1994, 30 (A), 289-291.
15. Hidalgo, I.J.; Borchardt, R.T. Transport of bile acids in a human intestinal epithelial cell line, Caco-2. Biochim. Biophys. Acta 1990, 7035(1), 97-103.
16. Artursson, P.; Karisson, J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 175 (3), 880-885.
17. Rubas, W.; Jezyk, N.; Grass, G.M. Comparison of the permeability characteristics of a human colonie epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharm. Res. 1993, 10 (1), 113-118.
18. Lennemàs, H.; Palm, K.; Fagerholm, U.; Artursson, P. Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Int. J. Pharm. 1996, 127,103-107.
19. Yee, S. In vitro permeability across Caco-2 cells (colonie) can predict in vivo (small Intestine) absorption in man-myth or fact. Pham. Res. 1997, 14 (6), 763-766.
20. Bailey, C.A.; Bryla, P.; Malick, A.W. The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development. Adv. Drug Delivery Rev. 1996, 22, 85-103.
21. Chong, S.; Dando, S.A.; Soucek, K.M.; Morrison, R.A. In vitro permeability through Caco-2 ceils is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transport system. Pharm. Res. 1996, 13 (1), 120-123.
22. Grés, M.C.; Julian, B.; Bourrié, M.; Meunier, V.; Roques, C.; Berger, M.; Boulenc, X.; Berger, Y.; Fabre, G. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm. Res. 1998, 15(5), 726-733.
23. Biganozoli, E.; Cavenaghi, LA.; Rossi, R.; Brunati, M.C.; Molli, M.L. Use of a Caco-2 cell culture model for the characterization of intestinal absorption of antibiotics. Farmaco 1999, 54, 594-599.
24. Camenisch, G.; Alsenze, J.; van de Waterbeemb, H.; Folkers, G. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. Eur. J. Pharm. Sci. 1998, 6 (4), 317-324.
25. Audus, K.L; Bartel, R.L; Hidalgo, I.J.; Borchardt, R.T. The use of cultured epithelial and endotheiial cells for drug transport and metabolism studies. Pharm Res. 1990, 7(5), 435-451.
26. Hilgers, A.R.; Conradi, R.A.; Burton, P.S. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm. Res. 1990, 7(9), 902-910.
27. Artursson, P.; Ungell, A.L.; Löfroth, J.E. Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm. Res. 1993, 10(8), 1123-1129.
28. Briske-Anderson, M.J.; Rnely, J.W.; Newman, S.M. The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. Proc. Soc. Exp. Biol. Med. 1997, 214(3), 248-257.
29. Cogbum, J.N.; Donovan, M.G.; Schasteen, C.S. A model of human small intestine absorptive cells. 1. Transport barrier. Pharm. Res. 1991, B (2), 210-216.
30. Gan, L.S.; Hsyu, P.H.; Pritchard, J.F.; Thakker, D. Mechanism of intestinal absorption of ranitidine and ondansetron: transport across Caco-2 cell monolayers. Pharm. Res. 1993, rO(12), 1722-1725.
31. Hidalgo, I.J.; Hillgreen, K.M.; Grass, G.M.; Borchardt, R.T. Characterization of the unstirred water layer in Caco-2 cell monolayers using a novel diffusion apparatus. Pharm. Res. 1991. 8(2), 222-227.
32. Hu, M; Borchardt, R.T. Mechanism of L-a-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2). Pharm. Res. 1990, 7(12), 1313-1319.
33. Karlsson, J.; Artursson, P. A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monoiayers of intestinal epithelial (Caco-2) cells grown in permeable filter chambers. Int. J. Pharm. 1991, 71, 55-64.
34. Kuhfeld, M.T.; Stratford, R.E. In vitro measurement of drug transport using a new diffusion chamber compatible with Miliicell culture supports: performance with Caco-2 monolayers. Int. J. Pharm. 1996, 133, 47-58.
35. Lu, S.; Gough, A.W.; Bobrowski, W.F.; Stewart, B.H. Transport properties are not altered across Caco-2 cells with heightened TEER despite underlying physiological and ultrastructural changes. J. Pharm. Sci. 1996, 85 (3), 270-273.
36. Pade, V.; Stavchansky, S. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model. Pharm. Res. 1997, 14 (9), 1210-1215.
37. Yu, H.; Cook, T.J.; Sinko, P.J. Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages. Pharm. Res. 1997, 14 (6), 757-762.
38. Adson, A.; Burton, P.S.; Raub, T.J.; Barshun, C.L.; Audus, K.L.; Ho, N.F. Passive diffusion of weak organic electrolytes across Caco2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. J. Pharm. Sci. 1995, 84 (10), 1197-1204.
39. Caldwell, G.W.; Easlick, S.M.; Gunnel, J.; Masucci, J.A.; Demarest, K. In vitro permeability of eight /3-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray lonization mass spectrometry. J. Mass Spectrom. 1998, 33 (7), 607-614.
40. Higendorf, C.; Spahn-Langguth, H.; Regàrdh, G.G.; Lipka, E.; Amidon, G.L.; Langguth, P. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J. Pharm. Scl. 2000,89 (1), 63-75.
41. Palm, K.; Luthman, K.; Ros, J.; Gràsjo, J.; Artursson, P. Effect of molecular charge on intestinal drug transport: pH dependent transport of cationic drugs. J. Pharmacol. Exp. Ther. 1999, 291 (2), 435443.
42. Hosoya, K.I.; Kim, K.J.; Lee, V.H. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers. Pharm. Res. 1996, 13 (6), 885-890.
43. Wilson, G.; Hassan, I.F.; Dix, C.J; Williamson, I.; Shah, R.; Mackay, M.; Artursson, P. Transport and permeability properties of human Caco-2 cells: an in vitro model of the intestinal epithelial cell barrier. J. Controlled Release 1990, 11, 25-40.
44. Artursson, P.; Borchardt, R.T. Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm. Res. 1997, 14 (12), 1655-1658.
45. Artursson, P.; Palm, K.; Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Delivery Rev. 1996, 22, 67-84.
46. Mainprize, T.; Grady, L.T. Standardization of an In Vitro Method of Drug Absorption. PF24(2), 1998, 6015-6023.
47. <1089> In Vitro Absorption-Indicating Cell Culture System. Pharmacopeial Previews, PF25(5), 1999, 8733-8737.
48. Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, August 2000.
49. Vachon, P.H.; Beaulieu, J.F. Transient mosaic patterns of morphological and functional differentiation in the Caco-2 cell line. Gastroenterology\992, 103(2), 414-423.
50. Walter, E.; Kissel, T. Heterogeneity in the human intestinal cell line Caco-2 leads to differences in transepithelial transport. Eur. J. Pharm. Sci. 1995, 3, 215-230.
51. BW Health Wire. NaviCyte, Inc. Press release. November 17, 1997. http://www.navicyte.com (accessed July 7, 1999).
52. Hidalgo, I.J.; Borchardt, R.T. Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2. Biochim. Biophys. Acta 1990, 1028 (1), 25-30.
53. Artursson, P. Cell cultures as models for drug absorption across the intestinal mucosa. Crtt Rev. Ther. Drug Carrier Syst. 1991, 8(4), 305-330.
54. Yu, H.; Sinko, P.J. Influence of the microporous substratum and hydrodynamics on resistances of drug transport in cell culture systems: calculation of intrinsic transport parameters. J. Pharm. Sci. 1997,56(12), 1448-57.
55. Tucker, S.P.; Meisen, L.R.; Compans.'R.W.; Migration of polarized cells through permeable membrane substrates of defined pore size. Eur. J. Cell Biol. 1992, 58 (2), 280-290.
56. Pauletti, G.M.; Audus, K.L.; Hidalgo, I.J. Effect of co-solvents on the physical barrier properties of Caco-2 cell monolayers. PharmSci 1998, 7(1). Abstract 1182.
57. Hidalgo, I.J.; Windisch. V.; Hu, H.; Furukawa, D.; Kardos P. Importance of establishing acceptance criteria for Caco-2 monolayers used in permeability studies. PharmSci 1998, 1 (1), Abstract 1197.
58. Faustino, P.; Volpe, DA; Knapton, A.D.; Ellison C.D.; Hussain A.S. Value of an internal standard approach for determining intestinal permeability class membership of drugs. PharmSci 1999. 1 (4), Abstract 4263.
59. Dowty, M.E.; Dietsch, C.R. Improved prediction of in vivo peroral absorption from in vitro intestinal permeability using an internal standard to control for intra- and inter-rat variability. Pharm. Res. 1997,14 (12), 1792-1797.
60. Bourdage, J.S.; Burton, P.S.; Cole, C.J.; Conradi, R.A.; Day, J.S.; Hilgers, A.R.; Pfund, W.P. Characterization of the Caco-2 permeability model and rat intestinal perfusion model for use with the BCS. PharmSci 1999, 1 (4), Abstract 4056.
61. Barthe, L; Woodley, J.; Houin, G. Gastrointestinal absorption of drugs: methods and studies. Fundam. Clin. Phamacol. 1999, 13(2), 154-168.
62. Collett, A.; Sims, E.; Walker, D.; He, Y.L.; Ayrton, J.; Rowland, M.; Warhurst, G. Comparison of HT29-18-C, and Caco-2 cell lines as models for studying intestinal paracellular drug absorption. Pharm. Res. 1996, 13 (2), 216-221.
63. Wils, P.; Warnery, A.; Phung-Ba, V.; Scherman, D. Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs. Cell Biol. Toxicol. 1994, 10 (5-6), 393397.
64. Collington, G.K.; Hunter, J.; Allen, C.N.; Simmons, N.L.; Hirst, B.H. Polarized efflux of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein from cultured epithelial cell monolayers. Biochem. Pharmacol. 1992,44(3), 417-424. -
65. Tavelin, S.; Milovic, V.; Ocklind, G.; Olsson, S.; Artursson, P. A conditionally immortalized epithelial cell line for studies of intestinal drug transport. J. Pharmacol. Exp. Ther. 1999, 290 (3), 1212-1221.
66. Irvine, J.D.; Takahashi, L.; Lockhart, K.; Cheong, J.; Tolan, J.W.; Selick, H.E.; Grove, J.R. MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J. Pharm. Scl. 1999, 88 (1), 28-33.
67. Ranaldi, G.; Islam, K.; Sambuy, Y. Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents. Antimicrob. Agents Chemother. 1992, 36(7), 1374-1381.
68. Lentz, K.A.; Hayashi, J.; Lucisano, L.J.; Poll!, J.E. Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system. Int. J. Pharm. 2000, 200 (1), 41-51.
69. Sweetland, R.L.; Polzer, R.J. Comparison of traditional 21-day Caco-2 cultures to Biocoat intestinal epithelium differentiation environment-cultured Caco-2 cells for the ability to predict active and passive transport. PharmSci 1999, 1 (1), Abstract 16.
70. Chong, S.; Dando, S.A.; Morrison, R.A. Evaluation of Biocoat intestinal epithelium differentiation environment (3-day cultured Caco2 cells) as an absorption screening model with Improved productivity. Pharm. Res. 1997, 14 (12), 1835-1837.
71. Stevenson, C.L.; Augustijns, P.F.; Hendren, R.W. Use of Caco2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures. Int. J. Pharm. 1999, 777(1), 103-115.
72. Garberg, P.; Eriksson, P.; Schipper, N.; Sjostrom, B. Automated absorption assessment using Caco-2 cells cultured on both sides of polycarbonate membranes. Pharm. Ras. 1999, 16(3), 441-445.
73. Lenz, K.O.; Aungst, B.J.; Lloyd, T.; Bulgarelli, J.P.; Tweed, J.A.; Maurin, M. Design and implementation of an automated system for maintaining Caco-2 cell cultures and high throughput permeability screening. PharmSci 1999, 1 (4), Abstract 2563.
74. Lennemas, H. Human intestinal permeability. J. Pharm. Scl. 1998, 87 (4), 403-10.